Double-Dummy, Parallel-Group, Multicenter, Event- Driven, Non-inferiority Study Comparing the Efficacy and Safety of Once-Daily Oral Rivaroxaban (BAY 59-7939) with Adjusted-Dose Oral Warfarin for the Prevention of stroke and Non-Central Nervous System

Date: August 06, 2012|Source: No Source